Literature DB >> 15385517

Host cell tropism underlies species restriction of human and bovine Cryptosporidium parvum genotypes.

Amna Hashim1, Marguerite Clyne, Grace Mulcahy, Donna Akiyoshi, Rachel Chalmers, Billy Bourke.   

Abstract

It has been recognized recently that human cryptosporidiosis is usually caused by Cryptosporidium parvum genotype I ("human" C. parvum), which is not found in animals. Compared to C. parvum genotype II, little is known of the biology of invasion of the human-restricted C. parvum genotype I. The aims of the present study were (i) to explore and compare with genotype II the pathogenesis of C. parvum genotype I infection by using an established in vitro model of infection and (ii) to examine the possibility that host-specific cell tropism determines species restriction among C. parvum genotypes by using a novel ex vivo small intestinal primary cell model of infection. Oocysts of C. parvum genotypes I and II were used to infect HCT-8 cells and primary intestinal epithelial cells in vitro. Primary cells were harvested from human endoscopic small-bowel biopsies and from bovine duodenum postmortem. C. parvum genotype I infected HCT-8 cells with lower efficiency than C. parvum genotype II. Actin colocalization at the host parasite interface and reduction in levels of invasion after treatment with microfilament inhibitors (cytochalasin B and cytochalasin D) were observed for both genotypes. C. parvum genotype II invaded primary intestinal epithelial cells, regardless of the species of origin. In contrast, C. parvum genotype I invaded only human small-bowel cells. The pathogenesis of C. parvum genotype I differs from C. parvum genotype II. C parvum genotype I does not enter primary bovine intestinal cells, suggesting that the species restriction of this genotype is due to host tissue tropism of the infecting isolate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385517      PMCID: PMC517554          DOI: 10.1128/IAI.72.10.6125-6131.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

Review 1.  Cryptosporidiosis: biology, pathogenesis and disease.

Authors:  Saul Tzipori; Honorine Ward
Journal:  Microbes Infect       Date:  2002-08       Impact factor: 2.700

Review 2.  'The glideosome': a dynamic complex powering gliding motion and host cell invasion by Toxoplasma gondii.

Authors:  Corinna Opitz; Dominique Soldati
Journal:  Mol Microbiol       Date:  2002-08       Impact factor: 3.501

Review 3.  Pathogenesis of Cryptosporidium parvum infection.

Authors:  F Laurent; D McCole; L Eckmann; M F Kagnoff
Journal:  Microbes Infect       Date:  1999-02       Impact factor: 2.700

4.  Intestinal epithelial cell apoptosis following Cryptosporidium parvum infection.

Authors:  D F McCole; L Eckmann; F Laurent; M F Kagnoff
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

5.  Variability among Cryptosporidium parvum genotype 1 and 2 immunodominant surface glycoproteins.

Authors:  K Sestak; L A Ward; A Sheoran; X Feng; D E Akiyoshi; H D Ward; S Tzipori
Journal:  Parasite Immunol       Date:  2002-04       Impact factor: 2.280

6.  Genetic analysis of a Cryptosporidium parvum human genotype 1 isolate passaged through different host species.

Authors:  D E Akiyoshi; X Feng; M A Buckholt; G Widmer; S Tzipori
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

7.  Genetic diversity of Cryptosporidium spp. in cattle in Michigan: implications for understanding the transmission dynamics.

Authors:  Michael M Peng; Mark L Wilson; Robert E Holland; Steven R Meshnick; Altaf A Lal; Lihua Xiao
Journal:  Parasitol Res       Date:  2003-02-26       Impact factor: 2.289

8.  Cryptosporidium hominis n. sp. (Apicomplexa: Cryptosporidiidae) from Homo sapiens.

Authors:  Una M Morgan-Ryan; Abbie Fall; Lucy A Ward; Nawal Hijjawi; Irshad Sulaiman; Ronald Fayer; R C Andrew Thompson; M Olson; Altaf Lal; Lihua Xiao
Journal:  J Eukaryot Microbiol       Date:  2002 Nov-Dec       Impact factor: 3.346

9.  Pathogenesis of human and bovine Cryptosporidium parvum in gnotobiotic pigs.

Authors:  Sonia J Pereira; Norma E Ramirez; Lihua Xiao; Lucy A Ward
Journal:  J Infect Dis       Date:  2002-08-05       Impact factor: 5.226

10.  Analysis of sequence diversity at the highly polymorphic Cpgp40/15 locus among Cryptosporidium isolates from human immunodeficiency virus-infected children in South Africa.

Authors:  Brett A Leav; Malanie R Mackay; Akudo Anyanwu; Roberta M O' Connor; Ana Maria Cevallos; Gurpreet Kindra; Nigel C Rollins; Michael L Bennish; Richard G Nelson; Honorine D Ward
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more
  9 in total

Review 1.  A hundred-year retrospective on cryptosporidiosis.

Authors:  Saul Tzipori; Giovanni Widmer
Journal:  Trends Parasitol       Date:  2008-03-07

2.  Interaction of Cryptosporidium hominis and Cryptosporidium parvum with primary human and bovine intestinal cells.

Authors:  Amna Hashim; Grace Mulcahy; Billy Bourke; Marguerite Clyne
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Glycoproteins and Gal-GalNAc cause Cryptosporidium to switch from an invasive sporozoite to a replicative trophozoite.

Authors:  Adam Edwinson; Giovanni Widmer; John McEvoy
Journal:  Int J Parasitol       Date:  2015-09-30       Impact factor: 3.981

4.  Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis.

Authors:  Nwakaso N Umejiego; Deviprasad Gollapalli; Lisa Sharling; Anna Volftsun; Jennifer Lu; Nicole N Benjamin; Adam H Stroupe; Thomas V Riera; Boris Striepen; Lizbeth Hedstrom
Journal:  Chem Biol       Date:  2008-01

5.  Downregulation of the goat beta-defensin-2 gene by IL-4 in caprine intestinal epithelial cells infected with Eimeria spp.

Authors:  F Ibarra-Velarde; Y Alcala-Canto
Journal:  Parasitol Res       Date:  2007-03-29       Impact factor: 2.289

6.  Cryptosporidium propidium monoazide-PCR, a molecular biology-based technique for genotyping of viable Cryptosporidium oocysts.

Authors:  Cristin C Brescia; Shannon M Griffin; Michael W Ware; Eunice A Varughese; Andrey I Egorov; Eric N Villegas
Journal:  Appl Environ Microbiol       Date:  2009-09-11       Impact factor: 4.792

7.  A screening pipeline for antiparasitic agents targeting cryptosporidium inosine monophosphate dehydrogenase.

Authors:  Lisa Sharling; Xiaoping Liu; Deviprasad R Gollapalli; Sushil K Maurya; Lizbeth Hedstrom; Boris Striepen
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10

8.  An Irish perspective on Cryptosporidium. Part 1.

Authors:  Annetta Zintl; Grace Mulcahy; Theo de Waal; Valerie de Waele; Catherine Byrne; Marguerite Clyne; Nicholas Holden; Seamus Fanning
Journal:  Ir Vet J       Date:  2006-08-01       Impact factor: 2.146

9.  The in vitro and ex vivo effect of Auranta 3001 in preventing Cryptosporidium hominis and Cryptosporidium parvum infection.

Authors:  Alexandros Ch Stratakos; Filip Sima; Patrick Ward; Mark Linton; Carmel Kelly; Laurette Pinkerton; Lavinia Stef; Ioan Pet; Tiberiu Iancu; Gratiela Pircalabioru; Nicolae Corcionivoschi
Journal:  Gut Pathog       Date:  2017-08-31       Impact factor: 4.181

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.